Lucio Giustini

2.0k total citations
41 papers, 1.3k citations indexed

About

Lucio Giustini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lucio Giustini has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Lucio Giustini's work include Colorectal Cancer Treatments and Studies (16 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Lucio Giustini is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Lucio Giustini collaborates with scholars based in Italy, United States and Japan. Lucio Giustini's co-authors include Renato Bisonni, Vincenzo Catalano, Francesco Graziano, Alfredo Falcone, Fotios Loupakis, Daniele Santini, Paolo Giordani, Annamaria Ruzzo, Mauro Magnani and Giuseppe Tonini and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Lucio Giustini

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucio Giustini Italy 20 884 407 385 322 294 41 1.3k
Denise D. Tsao‐Wei United States 5 817 0.9× 265 0.7× 558 1.4× 255 0.8× 329 1.1× 7 1.4k
E. Marcuello Spain 13 749 0.8× 167 0.4× 521 1.4× 187 0.6× 248 0.8× 38 1.1k
L Herrera United States 12 1.1k 1.2× 407 1.0× 206 0.5× 398 1.2× 488 1.7× 28 1.5k
Rodolfo Mattioli Italy 17 707 0.8× 306 0.8× 298 0.8× 141 0.4× 145 0.5× 61 995
L. Leong United States 16 648 0.7× 241 0.6× 199 0.5× 238 0.7× 144 0.5× 41 1.0k
Eugenio Marcuello Spain 17 1.4k 1.6× 385 0.9× 233 0.6× 451 1.4× 367 1.2× 33 1.6k
Pei-Rong Ding China 20 1.2k 1.3× 271 0.7× 195 0.5× 532 1.7× 145 0.5× 45 1.6k
Yihebali Chi China 16 1.5k 1.7× 817 2.0× 308 0.8× 378 1.2× 238 0.8× 67 2.0k
Chiara Pierantoni Italy 16 809 0.9× 366 0.9× 340 0.9× 155 0.5× 154 0.5× 40 1.3k
C. Calandri Italy 15 944 1.1× 920 2.3× 387 1.0× 99 0.3× 136 0.5× 24 1.5k

Countries citing papers authored by Lucio Giustini

Since Specialization
Citations

This map shows the geographic impact of Lucio Giustini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucio Giustini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucio Giustini more than expected).

Fields of papers citing papers by Lucio Giustini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucio Giustini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucio Giustini. The network helps show where Lucio Giustini may publish in the future.

Co-authorship network of co-authors of Lucio Giustini

This figure shows the co-authorship network connecting the top 25 collaborators of Lucio Giustini. A scholar is included among the top collaborators of Lucio Giustini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucio Giustini. Lucio Giustini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galosi, Andrea Benedetto, Marina Scarpelli, Roberta Mazzucchelli, et al.. (2014). Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. Diagnostic Pathology. 9(1). 90–90. 25 indexed citations
2.
Rastelli, Francesca, et al.. (2013). Medical oncologist's commitment in end-of-life care of cancer patients. Palliative & Supportive Care. 12(5). 351–354. 7 indexed citations
3.
Catalano, Vincenzo, Renato Bisonni, Francesco Graziano, et al.. (2012). A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer. 16(3). 411–419. 28 indexed citations
4.
Scartozzi, Mario, Riccardo Giampieri, Elena Maccaroni, et al.. (2012). Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. Journal of Translational Medicine. 10(1). 71–71. 24 indexed citations
5.
6.
Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2011). Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Annals of Oncology. 23(1). 135–141. 88 indexed citations
7.
Scartozzi, Mario, Alessandra Mandolesi, Riccardo Giampieri, et al.. (2011). The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan/cetuximab.. Journal of Clinical Oncology. 29(4_suppl). 404–404. 2 indexed citations
8.
Scartozzi, Mario, Alessandra Mandolesi, Riccardo Giampieri, et al.. (2010). Insulin‐like growth factor 1 expression correlates with clinical outcome in K‐RAS wild type colorectal cancer patients treated with cetuximab and irinotecan. International Journal of Cancer. 127(8). 1941–1947. 64 indexed citations
9.
Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. British Journal of Cancer. 100(6). 881–887. 158 indexed citations
10.
Braconi, Chiara, R. Bracci, Italo Bearzi, et al.. (2008). KIT and PDGFRα mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. Annals of Oncology. 19(4). 706–710. 27 indexed citations
11.
Ruzzo, Annamaria, Emanuele Canestrari, Fotios Loupakis, et al.. (2008). Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. The Pharmacogenomics Journal. 9(1). 78–84. 25 indexed citations
12.
Graziano, Francesco, Annamaria Ruzzo, Fotios Loupakis, et al.. (2008). Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy. British Journal of Cancer. 99(5). 716–721. 23 indexed citations
13.
Gridelli, Cesare, Carmine Ferrara, Ciro Guerriero, et al.. (2007). Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study. Journal of Thoracic Oncology. 2(6). 475–480. 21 indexed citations
14.
Ruzzo, Annamaria, Emanuele Canestrari, Paolo Enrico Maltese, et al.. (2007). Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 45(7). 822–8. 56 indexed citations
15.
Ruzzo, Annamaria, Francesco Graziano, Kazuyuki Kawakami, et al.. (2006). Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy. Journal of Clinical Oncology. 24(12). 1883–1891. 113 indexed citations
16.
Graziano, Francesco, Kazuyuki Kawakami, Annamaria Ruzzo, et al.. (2005). Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at‐risk Italian population. International Journal of Cancer. 118(3). 628–632. 57 indexed citations
17.
Giustini, Lucio, et al.. (1997). Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients. Breast Cancer Research and Treatment. 45(3). 205–210. 2 indexed citations
18.
Giustini, Lucio, et al.. (1996). Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy. Supportive Care in Cancer. 4(4). 287–290. 7 indexed citations
19.
Giustini, Lucio, et al.. (1984). A Long-Term Clinical Experience with Lonidamine. Oncology. 41(1). 39–47. 10 indexed citations
20.
Martino, C. De, R. Cavaliere, M. Bellocci, et al.. (1984). Morphological Damage Induced in vivo by Lonidamine on Human Metastatic Cancer Cells. Oncology. 41(1). 94–103. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denise D. Tsao‐Wei Breakdown of academic impact, for papers by E. Marcuello Breakdown of academic impact, for papers by L Herrera Breakdown of academic impact, for papers by Rodolfo Mattioli Breakdown of academic impact, for papers by L. Leong Breakdown of academic impact, for papers by Eugenio Marcuello Breakdown of academic impact, for papers by Pei-Rong Ding Breakdown of academic impact, for papers by Yihebali Chi Breakdown of academic impact, for papers by Chiara Pierantoni Breakdown of academic impact, for papers by C. Calandri
Rankless by CCL
2026